Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution

LinkedIn +

Biotechnology company and Covid-19 vaccine producer Moderna, has partnered with Kuehne+Nagel for an international supply chain arrangement for the distribution and storage of the vaccine.

Kuehne+Nagel will support the worldwide distribution of vaccine doses from Moderna’s international supply chain, based in Europe. This will include distribution to markets in Europe, Asia, Middle East and Africa, and parts of the Americas.

Dan Staner, Vice President Head of EMEA region said: “We are proud to be partnering with Kuehne+Nagel from Europe to support the distribution of vaccines to global citizens. Following the recent approvals, this is another step closer to resolving the pandemic and an exciting time for both our companies and everyone involved.”

The arrangement includes the distribution and warehousing of the vaccine from Kuehne+Nagel’s pharmaceutical hub in Europe. Kuehne+Nagel will use its network of more than 230 operations worldwide to distribute the vaccine via road and air.

At all stages of transport and storage, product integrity at the required temperature of -20°C will be maintained.

Robert Coyle, Senior Vice President, Pharma & Healthcare, Kuehne + Nagel International AG concludes: “With today’s announcement, we take on the responsibility to distribute Covid-19 Vaccine Moderna around the world.

Share this story: